Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract.
about
Chimeric virus-like particles containing influenza HA antigen and GPI-CCL28 induce long-lasting mucosal immunity against H3N2 virusesT cell-mediated host immune defenses in the lungProphylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenzaConserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine developmentRationale for treating human influenza infections by passive transfer of specific antibodies.Harnessing Local Immunity for an Effective Universal Swine Influenza VaccineRespiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.Generation of human neutralizing monoclonal antibodies against the 2009 pandemic H1N1 virus from peripheral blood memory B lymphocytesEvaluation of neutralizing efficacy of monoclonal antibodies specific for 2009 pandemic H1N1 influenza A virus in vitro and in vivo.Adjuvants and immunization strategies to induce influenza virus hemagglutinin stalk antibodiesSimplifying influenza vaccination during pandemics: sublingual priming and intramuscular boosting of immune responses with heterologous whole inactivated influenza vaccine.Mucosal immunization in perspective.Direct administration in the respiratory tract improves efficacy of broadly neutralizing anti-influenza virus monoclonal antibodies.Prolonged protection against Intranasal challenge with influenza virus following systemic immunization or combinations of mucosal and systemic immunizations with a heat-labile toxin mutant.Pathology of human influenza revisited.A pilot study of the immune response to whole inactivated avian influenza H7N1 virus vaccine in mice.Prospects for developing an effective particle-mediated DNA vaccine against influenza.Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge.An adjuvant for the induction of potent, protective humoral responses to an H5N1 influenza virus vaccine with antigen-sparing effect in mice.Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 HemagglutininsConsensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses.Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunityThe development of an AIDS mucosal vaccine.A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.Influenza viruses: from birds to humans.Microneedle and mucosal delivery of influenza vaccines.Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccineIntranasal immunization of baculovirus displayed hemagglutinin confers complete protection against mouse adapted highly pathogenic H7N7 reassortant influenza virusInduction of influenza-specific mucosal immunity by an attenuated recombinant Sendai virus.Inhibition of HIV-1 infectivity and epithelial cell transfer by human monoclonal IgG and IgA antibodies carrying the b12 V region.Identification of a novel antigen-presenting cell population modulating antiinfluenza type 2 immunity.Intranasal immunization with W 80 5EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse model.Vaccination with M2e-based multiple antigenic peptides: characterization of the B cell response and protection efficacy in inbred and outbred mice.Linking influenza virus tissue tropism to population-level reproductive fitnessMyD88 signaling is indispensable for primary influenza A virus infection but dispensable for secondary infectionAntiviral B cell and T cell immunity in the lungs.The magnitude of local immunity in the lungs of mice induced by live attenuated influenza vaccines is determined by local viral replication and induction of cytokinesC-type lectin-like receptor LOX-1 promotes dendritic cell-mediated class-switched B cell responses.Residual baculovirus in insect cell-derived influenza virus-like particle preparations enhances immunogenicity.
P2860
Q28365124-AE43C43F-CA2B-41E5-B350-C1FA53860109Q28395374-7E339ECA-8501-4B0D-A6BF-10E7654E6FA8Q28757651-2CBD41ED-E1D0-4A41-B56B-2C45DE0D204DQ30226873-D2A9EC07-AAAB-4823-A5A2-C092DBAFF161Q30230073-F263EBBB-B7F5-4847-B256-B41CE27DA7EEQ30234558-017C055C-8420-4EA0-9AEE-43D3D6590E60Q30240274-0C4E654A-20C4-4D31-9F41-2BA13A86F01FQ30352589-9ED03248-C06D-448A-8201-9D10E1A607DCQ30353823-33910540-8057-4741-AA00-FA13FBE2ABC6Q30355516-C56121B8-2E0E-4F51-A4AD-CC1A977D6871Q30358537-E768D760-E28D-4CA3-A578-C7EC43814CE9Q30368932-9989840F-82B2-4DD8-B273-A4932AC83E0BQ30374373-CEA1FD55-B24D-4474-94A6-B901DDC81F77Q30374752-3CEA75CD-1B93-4B1C-A768-F7599C562ACAQ30375055-4ADD35CE-AA1A-4F4A-842F-0FB2DFFC7534Q30377228-93D52A72-17DF-49CA-B6CC-2BBF3154C2F2Q30380300-EF5A3935-02D1-453B-A006-460B65208D1DQ30389916-8A162615-E9FC-43CB-95F3-F26F45C3E9F4Q30390234-415EAE23-6F48-44E7-AC71-BBA5AEC19A95Q30392944-9B10A520-C29E-4D29-86B2-7EA52230628FQ30398228-074CC122-7A2C-43BA-A85E-38E084BD084DQ30398435-63EE0392-AE29-44EC-871B-1BE4B8FC2C10Q30399285-4D34D3DE-73DF-474A-AB26-FBD17188FC85Q30408103-1E0FF0C2-A0F0-4128-8447-B3E88D0AAA87Q30411637-8B4A6833-2A9D-4E43-95AA-06E3D1B8BFFDQ30411865-5C2ADBDA-8921-42AD-9B4A-70579AABEBC8Q30418015-8FC83890-47FB-42A4-A6A8-1F15B722BEC5Q30421413-C3D6DAB9-7DBE-47E5-8D6D-4B95572BF11FQ30431867-8C43227B-204A-4442-8A50-09043D18E772Q33886452-7B9348AD-31C7-44E9-9894-82E8DA29150AQ33897480-F0BECF7E-3C8A-495B-BC46-D711FBB68E0DQ33979910-D08B454E-93D1-4832-A621-EBA2D38286D5Q34033869-42DBC738-C7DD-466E-8E19-F9FD551F5BA5Q34105207-2B170D21-5CC3-4D65-AD1B-172884E85E05Q34404965-D11BE815-A86A-44AD-BCF4-D5668F2713E6Q34416382-309892A4-930D-43A5-B753-9AABCCDB784CQ34454614-27891C08-23A1-48F7-BE60-88ECB9166FA9Q34458066-D12AD758-F7AD-4A70-8875-F932375D229EQ34458766-C21CED2C-4A9C-4301-8457-C42D09274676Q34511080-B49E4AC4-7FAE-4343-B7C1-AD72887DC344
P2860
Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Role of IgA versus IgG in the ...... the murine respiratory tract.
@en
Role of IgA versus IgG in the ...... the murine respiratory tract.
@nl
type
label
Role of IgA versus IgG in the ...... the murine respiratory tract.
@en
Role of IgA versus IgG in the ...... the murine respiratory tract.
@nl
prefLabel
Role of IgA versus IgG in the ...... the murine respiratory tract.
@en
Role of IgA versus IgG in the ...... the murine respiratory tract.
@nl
P2093
P1476
Role of IgA versus IgG in the ...... the murine respiratory tract.
@en
P2093
Kathryn B Renegar
Lou G Boykins
Parker A Small
Peter F Wright
P304
P356
10.4049/JIMMUNOL.173.3.1978
P407
P577
2004-08-01T00:00:00Z